Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2022 Filed Mar 16, 2022 15:16 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 2,940 | $374.45 | $1,100,880.65 |
DisclosureSEC source: 0001562180-22-002665 · primarydocument.xml · nonDerivative · entry 9 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,571.8424 F7 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $373.86 to $374.83, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 15:16 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 900 | $372.92 | $335,631.60 |
DisclosureSEC source: 0001562180-22-002665 · primarydocument.xml · nonDerivative · entry 8 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,511.8424 F6 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $372.70 to $373.46, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 15:16 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 600 | $371.89 | $223,132.20 |
DisclosureSEC source: 0001562180-22-002665 · primarydocument.xml · nonDerivative · entry 7 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,411.8424 F5 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $371.65 to $372.40, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 15:16 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 446 | $370.94 | $165,440.62 |
DisclosureSEC source: 0001562180-22-002665 · primarydocument.xml · nonDerivative · entry 6 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,011.8424 F4 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $370.41 to $371.32, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 15:16 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 1,254 | $369.86 | $463,801.31 |
DisclosureSEC source: 0001562180-22-002665 · primarydocument.xml · nonDerivative · entry 5 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,457.8424 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $369.40 to $370.36, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 15:16 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 405 | $367.94 | $149,017.40 |
DisclosureSEC source: 0001562180-22-002665 · primarydocument.xml · nonDerivative · entry 4 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,711.8424 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $367.56 to $368.22, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 15:16 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 1,271 | $367.12 | $466,603.93 |
DisclosureSEC source: 0001562180-22-002665 · primarydocument.xml · nonDerivative · entry 3 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,116.8424 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $366.50 to $367.42, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 15:16 UTC |
Lai Quintin JVP Corp Development & Strategy
|
Exercise / conversionCommon Stock | 5,576 | $83.47 | $465,428.72 |
DisclosureSEC source: 0001562180-22-002665 · primarydocument.xml · nonDerivative · entry 2 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,387.8424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 15:16 UTC |
Lai Quintin JVP Corp Development & Strategy
|
Exercise / conversionCommon Stock | 2,440 | $94.27 | $230,018.80 |
DisclosureSEC source: 0001562180-22-002665 · primarydocument.xml · nonDerivative · entry 1 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,811.8424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2022 Filed Mar 28, 2023 20:26 UTC |
Green Eric MarkDirector · President & CEO
|
GiftCommon Stock | 2,700 | $371.47 | $1,002,969.00 |
DisclosureSEC source: 0001562180-23-003146 · primarydocument.xml · nonDerivative · entry 1 Green Eric Mark · CIK 0001336007 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,874.0865 F1 · kind: This transaction represents a charitable gift donation to a private, non-profit educational institution for which Mr. Green received no compensatory benefit and subject to the requirement that the shares were not sold for 60 days by the recipient Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:25 UTC |
MONTECALVO DAVID ASVP, Glob Ops and Supply Chain
|
GrantCommon Stock | 3,597 | $369.13 | $1,327,760.61 |
DisclosureSEC source: 0001562180-22-001906 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,731.42 F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld. The net shares were deferred as deferred stock units in the Non-Qualified Deferred Compensation (NQDC) plan for employees to be distributed in accordance with the terms of the NQDC plan and their individual elections Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:23 UTC |
Lai Quintin JVP Corp Development & Strategy
|
GrantCommon Stock | 3,138 | $369.13 | $1,158,329.94 |
DisclosureSEC source: 0001562180-22-001905 · primarydocument.xml · nonDerivative · entry 1 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,371.8424 F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld. The net shares were deferred as deferred stock units in the Non-Qualified Deferred Compensation (NQDC) plan for employees to be distributed in accordance with the terms of the NQDC plan and their individual elections Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:59 UTC |
MacKay Kimberly BanksSVP, GC & Corporate Secretary
|
Exercise / conversionCommon Stock | 310 | $369.13 | $114,430.30 |
DisclosureSEC source: 0001562180-22-001901 · primarydocument.xml · nonDerivative · entry 1 MacKay Kimberly Banks · CIK 0001835699 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:56 UTC |
Winters ChadVP, CAO & Corporate Controller
|
GrantStock Options (Right to buy) · Derivative | 1,036 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001885 · primarydocument.xml · derivative · entry 1 Winters Chad · CIK 0001811424 · VP, CAO & Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036 Underlying: Stock Options (Right to Buy) · 1,036 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:55 UTC |
Favorite Annette FSr. VP Human Resources Officer
|
GrantStock Options (Right to buy) · Derivative | 3,108 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001883 · primarydocument.xml · derivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,108 Underlying: Stock Options (Right to Buy) · 3,108 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:55 UTC |
Lai Quintin JVP Corp Development & Strategy
|
GrantStock Options (Right to buy) · Derivative | 1,812 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001884 · primarydocument.xml · derivative · entry 1 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,812 Underlying: Stock Options (Right to Buy) · 1,812 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:55 UTC |
MacKay Kimberly BanksSVP, GC & Corporate Secretary
|
GrantStock Options (Right to buy) · Derivative | 3,108 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001882 · primarydocument.xml · derivative · entry 1 MacKay Kimberly Banks · CIK 0001835699 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,108 Underlying: Stock Options (Right to Buy) · 3,108 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:54 UTC |
MONTECALVO DAVID ASVP, Glob Ops and Supply Chain
|
GrantStock Options (Right to buy) · Derivative | 2,848 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001880 · primarydocument.xml · derivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,848 Underlying: Stock Options (Right to Buy) · 2,848 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:52 UTC |
Abraham SiljiChief Digital & Trans Officer
|
GrantStock Options (Right to buy) · Derivative | 3,108 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001879 · primarydocument.xml · derivative · entry 1 Abraham Silji · CIK 0001733001 · Chief Digital & Trans Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,108 Underlying: Stock Options (Right to Buy) · 3,108 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:51 UTC |
Birkett BernardSr VP, CFO & Treasurer
|
GrantStock Options (Right to buy) · Derivative | 9,844 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001878 · primarydocument.xml · derivative · entry 1 Birkett Bernard · CIK 0001658001 · Sr VP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,844 Underlying: Stock Options (Right to Buy) · 9,844 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:51 UTC |
Green Eric MarkDirector · President & CEO
|
GrantStock Options (Right to buy) · Derivative | 31,088 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001877 · primarydocument.xml · derivative · entry 1 Green Eric Mark · CIK 0001336007 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,088 Underlying: Stock Options (Right to Buy) · 31,088 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 20:28 UTC |
Winters ChadVP, CAO & Corporate Controller
|
GrantCommon Stock | 414 | $369.13 | $152,819.82 |
DisclosureSEC source: 0001562180-22-001859 · primarydocument.xml · nonDerivative · entry 1 Winters Chad · CIK 0001811424 · VP, CAO & Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072.777 F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 20:28 UTC |
Favorite Annette FSr. VP Human Resources Officer
|
GrantCommon Stock | 2,490 | $369.13 | $919,133.70 |
DisclosureSEC source: 0001562180-22-001858 · primarydocument.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,136.9617 F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 20:27 UTC |
Birkett BernardSr VP, CFO & Treasurer
|
GrantCommon Stock | 4,346 | $369.13 | $1,604,238.98 |
DisclosureSEC source: 0001562180-22-001856 · primarydocument.xml · nonDerivative · entry 1 Birkett Bernard · CIK 0001658001 · Sr VP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,915 F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 20:27 UTC |
Abraham SiljiChief Digital & Trans Officer
|
GrantCommon Stock | 2,498 | $369.13 | $922,086.74 |
DisclosureSEC source: 0001562180-22-001857 · primarydocument.xml · nonDerivative · entry 1 Abraham Silji · CIK 0001733001 · Chief Digital & Trans Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,575.2997 F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 20:26 UTC |
Green Eric MarkDirector · President & CEO
|
GrantCommon Stock | 22,104 | $369.13 | $8,159,249.52 |
DisclosureSEC source: 0001562180-22-001855 · primarydocument.xml · nonDerivative · entry 1 Green Eric Mark · CIK 0001336007 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,922.0865 F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld Read SEC document |
| February 13, 2022 Filed Feb 14, 2022 22:24 UTC |
MONTECALVO DAVID ASVP, Glob Ops and Supply Chain
|
Tax withholdingCommon Stock | 27 | $391.20 | $10,562.40 |
DisclosureSEC source: 0001562180-22-001454 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,134.42 F1 · shares: Shares withheld to cover taxes related to Bonus and incentive shares granted on February 13, 2018. Read SEC document |
| February 13, 2022 Filed Feb 14, 2022 22:24 UTC |
Green Eric MarkDirector · President & CEO
|
Tax withholdingCommon Stock | 85 | $391.20 | $33,252.00 |
DisclosureSEC source: 0001562180-22-001453 · primarydocument.xml · nonDerivative · entry 1 Green Eric Mark · CIK 0001336007 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,818.0865 F1 · shares: Shares withheld to cover taxes related to Bonus and incentive shares granted on February 13, 2018. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 14:49 UTC |
Joseph MollyDirector
|
GrantPhantom Stock Unit · Derivative | 48 | $469.01 | $22,512.48 |
DisclosureSEC source: 0001562180-22-000060 · primarydocument.xml · derivative · entry 2 Joseph Molly · CIK 0001709261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 14:45 UTC |
BUTHMAN MARK ADirector
|
GrantPhantom Stock Unit · Derivative | 48 | $469.01 | $22,512.48 |
DisclosureSEC source: 0001562180-22-000059 · primarydocument.xml · derivative · entry 2 BUTHMAN MARK A · CIK 0001223783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,879.2996 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| October 29, 2021 Filed Nov 1, 2021 19:05 UTC |
Winters ChadVP, CAO & Corporate Controller
|
Tax withholdingCommon Stock | 47 | $429.88 | $20,204.36 |
DisclosureSEC source: 0001562180-21-006716 · primarydocument.xml · nonDerivative · entry 1 Winters Chad · CIK 0001811424 · VP, CAO & Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658.777 F1 · kind: Shares withheld solely for the purpose of satisfying tax liability on dividend accrued on restricted stock award vested on 10/29/2021 Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 17:48 UTC |
BUTHMAN MARK ADirector
|
GrantPhantom Stock Unit · Derivative | 53 | $424.54 | $22,500.62 |
DisclosureSEC source: 0001562180-21-006184 · primarydocument.xml · derivative · entry 2 BUTHMAN MARK A · CIK 0001223783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,831.2996 Underlying: Common Stock · 53 shares Expires not disclosed F1 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 17:49 UTC |
Joseph MollyDirector
|
GrantPhantom Stock Unit · Derivative | 28 | $424.54 | $11,887.12 |
DisclosureSEC source: 0001562180-21-006185 · primarydocument.xml · derivative · entry 2 Joseph Molly · CIK 0001709261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28 Underlying: Common Stock · 28 shares Expires not disclosed F1 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| September 26, 2021 Filed Sep 27, 2021 20:59 UTC |
MONTECALVO DAVID ASVP, Glob Ops and Supply Chain
|
Tax withholdingCommon Stock | 620 | $457.11 | $283,408.20 |
DisclosureSEC source: 0001562180-21-006112 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,161.42 F1 · kind: Shares withheld solely for the purpose of satisfying tax liability due upon vesting of restricted stock award. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 14:45 UTC |
Lai Quintin JVP Corp Development & Strategy
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $72.97 | $0.00 |
DisclosureSEC source: 0001562180-21-005939 · primarydocument.xml · derivative · entry 7 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2026-10-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 14:45 UTC |
Lai Quintin JVP Corp Development & Strategy
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,672 | $0.00 Strike: $59.64 | $0.00 |
DisclosureSEC source: 0001562180-21-005939 · primarydocument.xml · derivative · entry 6 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,672 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 14:45 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 1,500 | $462.63 | $693,945.90 |
DisclosureSEC source: 0001562180-21-005939 · primarydocument.xml · nonDerivative · entry 5 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,233.8424 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $462.48 to $462.805, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 14:45 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 3,100 | $460.80 | $1,428,493.95 |
DisclosureSEC source: 0001562180-21-005939 · primarydocument.xml · nonDerivative · entry 4 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,733.8424 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $460.50 to $461.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 14:45 UTC |
Lai Quintin JVP Corp Development & Strategy
|
SaleCommon Stock | 5,072 | $460.18 | $2,334,011.66 |
DisclosureSEC source: 0001562180-21-005939 · primarydocument.xml · nonDerivative · entry 3 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,833.8424 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $459.50 to $460.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 14:45 UTC |
Lai Quintin JVP Corp Development & Strategy
|
Exercise / conversionCommon Stock | 1,000 | $72.97 | $72,970.00 |
DisclosureSEC source: 0001562180-21-005939 · primarydocument.xml · nonDerivative · entry 2 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,905.8424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 14:45 UTC |
Lai Quintin JVP Corp Development & Strategy
|
Exercise / conversionCommon Stock | 8,672 | $59.64 | $517,198.08 |
DisclosureSEC source: 0001562180-21-005939 · primarydocument.xml · nonDerivative · entry 1 Lai Quintin J · CIK 0001744326 · VP Corp Development & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,905.8424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 14:51 UTC |
ZENNER PATRICK JDirector
|
GiftCommon Stock | 11,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-005919 · primarydocument.xml · nonDerivative · entry 2 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,681.85 F2 · kind: Mr. Zenner contributed 3,837 vested shares equally to 3 separate trusts for which neither he nor any family member who lives with him is a trustee or beneficiary. Mr. Zenner disclaims all pecuniary and voting interest in the shares contributed. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 20:37 UTC |
Joseph MollyDirector
|
GrantCommon Stock | 308 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-005541 · primarydocument.xml · nonDerivative · entry 1 Joseph Molly · CIK 0001709261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308 F1 · price: These shares of restricted stock units will vest in full on May 3, 2022 and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 18:58 UTC |
BUTHMAN MARK ADirector
|
GrantPhantom Stock Unit · Derivative | 63 | $359.10 | $22,623.30 |
DisclosureSEC source: 0001562180-21-004614 · primarydocument.xml · derivative · entry 2 BUTHMAN MARK A · CIK 0001223783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,778.2996 Underlying: Common Stock · 63 shares Expires not disclosed F1 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. F1 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 14:14 UTC |
Birkett BernardSr VP, CFO & Treasurer
|
Tax withholdingCommon Stock | 1,090 | $357.59 | $389,773.10 |
DisclosureSEC source: 0001562180-21-004421 · primarydocument.xml · nonDerivative · entry 1 Birkett Bernard · CIK 0001658001 · Sr VP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,569 F1 · kind: Shares withheld solely for the purpose of satisfying tax liability due upon vesting of restricted stock award. Read SEC document |
| May 19, 2021 Filed Feb 11, 2022 11:15 UTC |
Green Eric MarkDirector · President & CEO
|
GiftCommon Stock | 3,150 | $325.00 | $1,023,750.00 |
DisclosureSEC source: 0001562180-22-001350 · primarydocument.xml · nonDerivative · entry 1 Green Eric Mark · CIK 0001336007 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,903.0865 F1 · kind: This transaction represents a charitable gift donation to a private, non-profit educational institution for which Mr. Green received no compensatory benefit and subject to the requirement that the shares were not sold for 60 days by the recipient Read SEC document |
| May 10, 2021 Filed May 10, 2021 20:49 UTC |
Abraham SiljiChief Digital & Trans Officer
|
SaleCommon Stock | 2,171 | $335.00 | $727,285.00 |
DisclosureSEC source: 0001562180-21-003372 · primarydocument.xml · nonDerivative · entry 1 Abraham Silji · CIK 0001733001 · Chief Digital & Trans Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,077.2997 Read SEC document |
| May 05, 2021 Filed May 7, 2021 18:27 UTC |
Winters ChadVP, CAO & Corporate Controller
|
Tax withholdingCommon Stock | 10 | $328.60 | $3,286.00 |
DisclosureSEC source: 0001562180-21-003318 · primarydocument.xml · nonDerivative · entry 1 Winters Chad · CIK 0001811424 · VP, CAO & Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705.777 F1 · kind: Shares withheld solely for the purpose of satisfying tax liability due upon vesting of restricted stock award. Read SEC document |
| May 04, 2021 Filed May 6, 2021 23:31 UTC |
ZENNER PATRICK JDirector
|
GrantCommon Stock | 790 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-003314 · primarydocument.xml · nonDerivative · entry 1 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,508.85 F1 · price: These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. F2 · balance_after: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Read SEC document |
| May 04, 2021 Filed May 6, 2021 23:30 UTC |
FRIEL ROBERT FDirector
|
GrantCommon Stock | 577 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-003313 · primarydocument.xml · nonDerivative · entry 1 FRIEL ROBERT F · CIK 0001224110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,798.98 F1 · price: These shares of restricted stock units will vest in full on the first anniversary of the date of grant and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors. F2 · balance_after: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.